Anna R. Carta-Rosa

Via Ospedale 72
Cagliari, 09124, Italy

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells.

Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells.

Journal: Journal of neurology

Published: March 01, 2024

Region-specific changes in gene expression are associated with cognitive deficits in the alpha-synuclein-induced model of Parkinson's disease: A transcriptomic profiling study.

Region-specific changes in gene expression are associated with cognitive deficits in the alpha-synuclein-induced model of Parkinson's disease: A transcriptomic profiling study.

Journal: Experimental neurology

Published: July 31, 2023

Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodent.

Nanocrystals as an effective strategy to improve Pomalidomide bioavailability in rodent.

Journal: International journal of pharmaceutics

Published: February 16, 2022

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease.

Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease.

Journal: Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics

Published: December 24, 2021

The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications.

The role of glia in Parkinson's disease: Emerging concepts and therapeutic applications.

Journal: Progress in brain research

Published: April 06, 2020

Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species.

Advances in modelling alpha-synuclein-induced Parkinson's diseases in rodents: Virus-based models versus inoculation of exogenous preformed toxic species.

Journal: Journal of neuroscience methods

Published: December 27, 2019

Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function.

Neuroinflammation in L-DOPA-induced dyskinesia: beyond the immune function.

Journal: Journal of neural transmission (Vienna, Austria : 1996)

Published: November 07, 2017

Corrigendum to "Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice" [Neuroscience 302 (2015) 23-35].

Corrigendum to "Neuroprotective and anti-inflammatory properties of a novel non-thiazolidinedione PPARγ agonist in vitro and in MPTP-treated mice" [Neuroscience 302 (2015) 23-35].

Journal: Neuroscience

Published: October 23, 2016

Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.

Differential induction of dyskinesia and neuroinflammation by pulsatile versus continuous l-DOPA delivery in the 6-OHDA model of Parkinson's disease.

Journal: Experimental neurology

Published: August 31, 2016

Microglial phenotypes in Parkinson's disease and animal models of the disease.

Microglial phenotypes in Parkinson's disease and animal models of the disease.

Journal: Progress in neurobiology

Published: August 04, 2015

Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.

Dynamic changes in pro- and anti-inflammatory cytokines in microglia after PPAR-γ agonist neuroprotective treatment in the MPTPp mouse model of progressive Parkinson's disease.

Journal: Neurobiology of disease

Published: April 27, 2014

The MPTP/probenecid model of progressive Parkinson's disease.

The MPTP/probenecid model of progressive Parkinson's disease.

Journal: Methods in molecular biology (Clifton, N.J.)

Published: January 09, 2013

Showing 1-12 of 20

Last Updated: 09/26/2026